{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~11 mi. (Sankt Gallen, Switzerland, +199 more cities)
facility
Kantonsspital St. Gallen ( Site 0708)
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
city
~11 mi. (Sankt Gallen, Switzerland, +28 more cities)
facility
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2502)
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Investigational Agents for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)
city
~11 mi. (Sankt Gallen, Switzerland, +27 more cities)
facility
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502)
drug
favezelimab, +4 more drugs
drug type
immunotherapy, +1 more type
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
city
~11 mi. (Sankt Gallen, Switzerland, +34 more cities)
facility
Cantonal Hospital St.Gallen-Klinik für Gastroenterologie / Hepatologie ( Site 0334)
drug
lenvatinib, +2 more drugs
drug type
immunotherapy, +1 more type
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
city
~11 mi. (Sankt Gallen, Switzerland, +15 more cities)
facility
Kantonsspital St. Gallen
biomarker
ARID1A Loss, +125 more biomarkers
drug
elimusertib, +1 more drug
drug type
immunotherapy, +1 more type
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
city
~33 mi. (Ravensburg, Germany, +144 more cities)
facility
GSK Investigational Site
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~33 mi. (Ravensburg, Germany, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)
city
~33 mi. (Ravensburg, Germany, +76 more cities)
facility
Onkologie Ravensburg ( Site 1104)
drug
docetaxel, +1 more drug
drug type
chemotherapy, +1 more type